Home/Filings/4/0000950170-25-041302
4//SEC Filing

Wiley Matthew T. 4

Accession 0000950170-25-041302

CIK 0001813814other

Filed

Mar 17, 8:00 PM ET

Accepted

Mar 18, 4:45 PM ET

Size

5.5 KB

Accession

0000950170-25-041302

Insider Transaction Report

Form 4
Period: 2025-03-17
Wiley Matthew T.
Chief Commercial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-03-17+350,000350,000 total
    Exercise: $6.35Exp: 2035-03-16Common Shares (350,000 underlying)
Footnotes (1)
  • [F1]The shares underlying the option shall vest and become exercisable over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such vesting date

Documents

1 file

Issuer

Mind Medicine (MindMed) Inc.

CIK 0001813814

Entity typeother

Related Parties

1
  • filerCIK 0001759703

Filing Metadata

Form type
4
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 4:45 PM ET
Size
5.5 KB